MSLN-positive ovarian and colon cancer cells were used in vitro studies demonstrating markedly improved CAR-T cell activity with A2aR disruption, including increased cytokine generation and cytotoxicity. The gene discussed is MSLN; the disease is malignant colon neoplasm.